TE BioS

TE BioS is a global biotechnology company, located in Osong, South Korea. Since 2009, we have been dedicating to become the world’s best innovation company for better health and well-being We are a promising venture company, selected as “2020 Bio Grand Prize” from the press money today. Our goal is to “create a better life” for patients worldwide. Currently, we are focusing on “CorriX”, the next generation postbiotics that has been listed in “Nature”, the world’s leading science journal. CorriX is the world's first health functional food with an anti-cancer immune surveillance system. It was developed in Germany, and TE BioS has acquired property right from Avitop in 2019. CorriX has been approved by FDA (GRAS), and EFSA (Novel food), and we are expecting to get KFDA approval for health functional food in 2022.